Get Reliable Information about COVID-19
Follow this link to listen to a recording of Bryan Monroes’s March 17, 2020 video conference on the coronavirus pandemic. See below for who Bryan is.
Bryan Monroe is a process development/manufacturing professional who has been employed in the biotech industry for more than 30 years. During his career, Bryan has worked on a wide array of successful drug candidates including insulin, Factor X, Tretten, NovoSeven, Recothrom, Orencia, Nulojix and Provenge, as well as diagnostic kits for HIV-1, HIV-2 and HTLV-3. His role in these programs included development, optimization, scale-up and transfer of recombinant protein expression processes in yeast, E.coli, insect cells and mammalian cells. As a consultant, Bryan has contributed to the successful scale-up and/or transfer of more than 100+ unique therapeutic programs throughout the global market, targeting more efficient processes, reduced time to clinical investigation, cost of goods improvements, and the development of robust expression platforms.